The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 167.50
Bid: 165.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 5.00 (3.03%)
Open: 167.50
High: 167.50
Low: 167.50
Prev. Close: 167.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Syndicate Mid-point Forecasts

30 Mar 2020 07:00

RNS Number : 9443H
Helios Underwriting Plc
30 March 2020
 

30th March 2020

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid-point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2017 and 2018 years of account based on 4th quarter 2019 results.

 

Nigel Hanbury, Chief Executive, commented:

 

"As the only listed consolidator of private capital at Lloyd's, Helios offers a unique opportunity for growth and returns from exposure to the Lloyd's market through targeted acquisitions of the better quality syndicates. Our strategy is bringing results, with returns on average 3.1% better than the Lloyd's market itself.

 

"Given the current uncertainty we would expect the number of LLV's for sale to increase and we see opportunities to continue to build our core portfolio of capacity and achieve outperformance against the Lloyd's market as whole.

 

"We look forward to the future with confidence."

 

 

Year of Account

 

2017

2018

2019

2020

 

£m

£m

£m

£m

Capacity - Position as at 15th November 2019

56.1

59.0

55.7

62.9

Retained

30.7

20.7

16.7

18.9

Reinsured

25.4

38.2

39.0

44.1

 

 

 

 

 

Capacity acquired since 15th November 2019

 

 

 

 

Retained

6.6

6.8

6.6

2.2

Reinsured

0.0

0.0

0.0

5.1

 

 

 

 

 

Capacity - Position as at 26 March 2020

 

 

 

 

Retained

37.4

27.6

23.3

21.1

Reinsured

25.4

38.2

39.0

49.1

 

62.7

65.8

62.2

70.2

 

 

 

 

 

Mid-point forecast at 30th September 2019

-6.51%

-3.39%

 

 

Final result / Current mid-point forecast

-4.83%

-3.61%

 

 

 

 

 

 

 

Lloyd's Market Average

-7.97%

-5.71%

 

 

Helios out performance

3.14%

2.10%

 

 

 

Notes

1) The table above shows the capacity as at 30th March 2020 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. Helios acquired four limited liability vehicles during 2019 for a total consideration of £10.2m (£12.2m - 2018) and in 2020 to date a single LLV has been acquired for £1.2m

2) The result for the 2017 year of account and the mid point forecasts for 2018 year of account as of 4th quarter 2019 have been aggregated at syndicate level from estimates supplied by Managing Agents

3) The Helios outperformance is measured using the result on the capacity at the end of the year - including the capacity of the portfolios acquired which include participations on underperforming syndicates that will subsequently be discarded. The effect of excluding the acquired capacity and basing the Helios outperformance against the mid-point forecasts on the capacity at the start of the underwriting year - the core Helios portfolio - versus the Lloyds Market average is shown below:

 

 

2017

2018

Result / Current mid-point forecast Core Portfolio

-3.67%

-3.49%

Lloyd's Market Average

-7.97%

-5.71%

Helios out performance

4.30%

2.22%

 

4) The 2018 midpoint estimates have deteriorated as many syndicates have strengthened reserve estimates to take into consideration the increased level of uncertainty in certain lines of business, notably casualty for which strengthening has been reported across the market in aggregate. In addition, there has also been material strengthening reported in relation to estimates for Typhoon Jebi, consistent with the experience across the wider property and casualty industry.

5) The impact on Helios will be as follows:

a. The change in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2018.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive 07787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

Shore Capital

Robert Finlay 020 7408 4080

David Coaten

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £70m of capacity for the 2020 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPPURPWUPUGMM
Date   Source Headline
21st Nov 20177:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Sep 20177:00 amRNSHalf-year Report
26th Sep 20177:00 amRNSAcquisition of Inversanda LLP
16th Aug 20177:00 amRNSDirector/PDMR Shareholding
11th Aug 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20174:18 pmRNSResult of AGM and Directorate Change
9th Jun 20177:00 amRNSAcquisition of Nottus No 51 Limited
30th May 20177:00 amRNSFinal Results
23rd May 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
4th Apr 20177:00 amRNSAcquisition of Charmac
15th Mar 20177:00 amRNSQuarterly Syndicate Forecasts and Capacity Update
26th Jan 20177:00 amRNSAcquisition of Pooks
9th Jan 20174:34 pmRNSResult of General Meeting
22nd Dec 20167:00 amRNSProposed acquisition of Pooks Limited and GM
5th Dec 20167:01 amRNSUnderwriting Capacity
5th Dec 20167:00 amRNSAcquisition
29th Nov 20167:00 amRNSQuarterly Syndicate Forecasts
1st Nov 20162:56 pmRNSHolding(s) in Company
27th Oct 20161:22 pmRNSResults of GM and of Open Offer and TVR
10th Oct 201610:50 amRNSPosting of circular
6th Oct 20163:36 pmRNSHolding(s) in Company
30th Sep 20162:55 pmRNSResult of Placing and Open Offer Timetable
30th Sep 20167:01 amRNSProposed Placing and Open Offer
30th Sep 20167:00 amRNSHalf-year Report
25th Aug 201610:55 amRNSSyndicate Forecasts
3rd Aug 20164:29 pmRNSTotal Voting Rights
18th Jul 20165:14 pmRNSHolding(s) in Company
6th Jul 20165:30 pmRNSIssue of Equity
6th Jul 20165:30 pmRNSDirector/PDMR Shareholding
29th Jun 20169:35 amRNSResult of AGM
17th Jun 20167:00 amRNSScrip Dividend Reference Price
7th Jun 20165:38 pmRNSHolding(s) in Company
7th Jun 20167:00 amRNSSyndicate Forecasts
1st Jun 20165:41 pmRNSFinal Results - Replacement
31st May 20167:00 amRNSAppointment of Nominated Adviser and Broker
31st May 20167:00 amRNSAcquisition
31st May 20167:00 amRNSFinal Results
11th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20164:39 pmRNSChange of Registered Office
22nd Mar 20167:00 amRNSSyndicate Forecasts
17th Feb 20165:14 pmRNSDirector/PDMR Shareholding
22nd Jan 20167:00 amRNSAcquisition
3rd Dec 201511:34 amRNSSyndicate Forecasts
30th Sep 201510:47 amRNSTotal Voting Rights
25th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20158:19 amRNSAcquisition
24th Aug 20157:00 amRNSSyndicate Forecasts
3rd Aug 20157:00 amRNSAcquisition
15th Jul 20157:00 amRNSAcquisitions
3rd Jul 20151:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.